Comment le bénéfice par action récent de HAE se compare-t-il aux attentes ?
Comment les revenus de Haemonetics Corp HAE se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Haemonetics Corp ?
Quel est le score de qualité des bénéfices pour Haemonetics Corp ?
Quand Haemonetics Corp publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Haemonetics Corp ?
Haemonetics Corp a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$57.64
Prix d'ouverture
$57.84
Plage de la journée
$57.44 - $59.09
Plage de 52 semaines
$47.32 - $87.32
Volume
501.3K
Volume moyen
871.5K
BPA (TTM)
3.43
Rendement en dividend
--
Capitalisation boursière
$2.7B
Qu’est-ce que HAE ?
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). The company also offers solutions for structural heart and endovascular procedures.